Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Elford

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
American Journal of Hematology|March 8, 2000
Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocinW E Iyamu, S E Adunyah, H Fasold, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 27, 2005
Oxygen carriers: a selected reviewMohammed S Inayat, Andrew C Bernard, Vincent S Gallicchio, et al.
Antiviral Research|January 18, 2005
Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative diseaseChristopher N Mayhew, Ryan Sumpter, Mohammed Inayat, et al.
Journal of Inflammation (London, England)|August 20, 2010
Inhibition of allogeneic inflammatory responses by the Ribonucleotide Reductase Inhibitors, Didox and TrimidoxMohammed S Inayat, Ismail S El-Amouri, Mohammad Bani-Ahmad, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductaseT Szekeres, K Gharehbaghi, M Fritzer, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|November 1, 1995
Iron binding capacity of trimidox (3,4,5-trihydroxybenzamidoxime), a new inhibitor of the enzyme ribonucleotide reductaseT Szekeres, E Vielnascher, L Novotny, et al.
Life Sciences|August 26, 1998
Enhanced effects of adriamycin by combination with a new ribonucleotide reductase inhibitor, trimidox, in murine leukemiaM Fritzer-Szekeres, L Novotny, D Romanova, et al.
Life Sciences|February 24, 2001
The ribonucleotide reductase inhibitor trimidox induces c-myc and apoptosis of human ovarian carcinoma cellsG Rosenberger, G Fuhrmann, M Grusch, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|February 4, 1998
Effective use of ribonucleotide reductase inhibitors (Didox and Trimidox) alone or in combination with didanosine (ddI) to suppress disease progression and increase survival in murine acquired immunodeficiency syndrome (MAIDS)C Mayhew, O Oakley, J Piper, et al.
Blood|December 15, 1994
Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cellsT Szekeres, M Fritzer, H Strobl, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
American Journal of Hematology|March 8, 2000
Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocinW E Iyamu, S E Adunyah, H Fasold, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 27, 2005
Oxygen carriers: a selected reviewMohammed S Inayat, Andrew C Bernard, Vincent S Gallicchio, et al.
Antiviral Research|January 18, 2005
Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative diseaseChristopher N Mayhew, Ryan Sumpter, Mohammed Inayat, et al.
Journal of Inflammation (London, England)|August 20, 2010
Inhibition of allogeneic inflammatory responses by the Ribonucleotide Reductase Inhibitors, Didox and TrimidoxMohammed S Inayat, Ismail S El-Amouri, Mohammad Bani-Ahmad, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductaseT Szekeres, K Gharehbaghi, M Fritzer, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|November 1, 1995
Iron binding capacity of trimidox (3,4,5-trihydroxybenzamidoxime), a new inhibitor of the enzyme ribonucleotide reductaseT Szekeres, E Vielnascher, L Novotny, et al.
Life Sciences|August 26, 1998
Enhanced effects of adriamycin by combination with a new ribonucleotide reductase inhibitor, trimidox, in murine leukemiaM Fritzer-Szekeres, L Novotny, D Romanova, et al.
Life Sciences|February 24, 2001
The ribonucleotide reductase inhibitor trimidox induces c-myc and apoptosis of human ovarian carcinoma cellsG Rosenberger, G Fuhrmann, M Grusch, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|February 4, 1998
Effective use of ribonucleotide reductase inhibitors (Didox and Trimidox) alone or in combination with didanosine (ddI) to suppress disease progression and increase survival in murine acquired immunodeficiency syndrome (MAIDS)C Mayhew, O Oakley, J Piper, et al.
Blood|December 15, 1994
Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cellsT Szekeres, M Fritzer, H Strobl, et al.
Pageof 7